Vasella wins chairman role at Alcon

Novartis Chairman Daniel Vasella (photo) was elected to the additional position of board chairman of Alcon, a move that further asserts Novartis's control of the eye-care company as it seeks to buy the 23 percent it doesn't already own. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.